SCHEMBL20174402

SCHEMBL20174402

c1ccc2c(c1)-c1ccc(-c3nc(-c4ccc5ccccc5c4)nc(-c4ccc5ccccc5c4)n3)cc1C21c2ccccc2-c2c1oc1ccccc21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
PIM1 P11309 1/20 0.31
GPR84 Q9NQS5 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
MAOB P27338 1/20 0.30
KMT2A Q03164 2/20 0.30
KDM4E B2RXH2 2/20 0.30
ALDH1A1 P00352 2/20 0.30
TP53 P04637 2/20 0.30
HSD17B10 Q99714 2/20 0.30
MEN1 O00255 1/20 0.30
GRM4 Q14833 2/20 0.30
MAPK1 P28482 1/20 0.30
NQO1 P15559 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174375 0.94 ALDH1A1 (0.34) CYP1A2SMN1; SMN2PIM1GPR84KMT2A
SCHEMBL20174415 0.94 ALK (0.34)
SCHEMBL20174378 0.93 KMT2A (0.33) CYP1A2SMN1; SMN2GPR84KMT2AKDM4E
SCHEMBL20174384 0.93 CYP1A1 (0.40) CYP1A2SMN1; SMN2PIM1GPR84MAOB
SCHEMBL20174368 0.90 CYP1A1 (0.38) CYP1A2SMN1; SMN2PIM1MAOBKMT2A
SCHEMBL20174362 0.90 CYP1A1 (0.38) CYP1A2SMN1; SMN2PIM1MAOBKMT2A
SCHEMBL20174380 0.89 CYP1A1 (0.39) CYP1A2SMN1; SMN2PIM1MAOBKMT2A
SCHEMBL20174369 0.89 CYP1A1 (0.39) CYP1A2SMN1; SMN2PIM1MAOBKMT2A
SCHEMBL20174371 0.89 CYP1A1 (0.36) CYP1A2SMN1; SMN2PIM1MAOBKMT2A
SCHEMBL20174385 0.89 KMT2A (0.34) CYP1A2SMN1; SMN2GPR84KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG CYP1A2 436/4885SMN1; SMN2 3407/4885PIM1 2804/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG CYP1A2 436/4885SMN1; SMN2 3407/4885PIM1 2804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.